Intuitive Surgical, Inc. $ISRG Stake Raised by Trilogy Capital Inc.

Trilogy Capital Inc. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,406 shares of the medical equipment provider’s stock after buying an additional 1,038 shares during the quarter. Trilogy Capital Inc.’s holdings in Intuitive Surgical were worth $2,418,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. Tobam grew its stake in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in Intuitive Surgical in the second quarter worth about $27,000. Princeton Global Asset Management LLC bought a new position in Intuitive Surgical in the 2nd quarter valued at about $30,000. Riggs Asset Managment Co. Inc. increased its stake in Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares during the period. Finally, First Command Advisory Services Inc. raised its position in shares of Intuitive Surgical by 3,750.0% during the 2nd quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock worth $42,000 after buying an additional 75 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 104 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $559.90, for a total value of $58,229.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 464 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36. Following the sale, the senior vice president owned 131 shares in the company, valued at $71,852.19. This represents a 77.98% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 114,007 shares of company stock valued at $63,533,844. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.2%

Shares of NASDAQ ISRG opened at $586.24 on Monday. The stock has a market capitalization of $210.16 billion, a price-to-earnings ratio of 77.55, a PEG ratio of 4.77 and a beta of 1.67. The stock’s fifty day simple moving average is $565.95 and its 200 day simple moving average is $511.38. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the business posted $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent analyst reports. Leerink Partners increased their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Argus upped their target price on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $622.17.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.